We are live on ! Find out more
MBIO icon

Mustang Bio

35 hedge funds and large institutions have $7.25M invested in Mustang Bio in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

3% less funds holding

Funds holding: 3635 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

54% less capital invested

Capital invested by funds: $15.8M → $7.25M (-$8.59M)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
11
Closed
5
Calls
Puts
Net Calls
Net Calls Change

MBIO Hedge Fund Activity: Q4 2018 in Review

35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2018, worth a combined $7.25M — down 54% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MBIO and 4 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.

The largest buyer was Fenimore Asset Management, opening a new position worth an estimated $155K. The largest seller was Vanguard Group, cutting an estimated $1.08M.

  • 35 institutional investors held Mustang Bio (MBIO) as of Q4 2018, down from 36 in Q3 2018.
  • Funds reported $7.25M of Mustang Bio stock for Q4 2018, down 54% quarter-over-quarter.
  • 4 funds opened new Mustang Bio positions in Q4 2018 and 5 closed out, a net change of -1 holder.
  • The largest Mustang Bio buyer in Q4 2018 was Fenimore Asset Management, an estimated $155K added.
  • The largest Mustang Bio seller in Q4 2018 was Vanguard Group, an estimated $1.08M sold.

Based on aggregated 13F filings for Q4 2018.